{"name":"Nautilus Biotechnology","slug":"nautilus","ticker":"NAUT","exchange":"NASDAQ","domain":"nautilus.bio","description":"Nautilus Biotechnology is a biotechnology company focused on proteomics and life sciences tools. The company has developed a proprietary platform for protein-based therapeutics. Nautilus is positioned to capitalize on the growing demand for protein-based treatments. Its platform has the potential to accelerate the development of new therapies.","hq":"Seattle, WA","founded":0,"employees":"","ceo":"Sujal Patel","sector":"Proteomics / Life Sciences Tools","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$280M","metrics":{"revenue":2500000,"revenueGrowth":0,"grossMargin":0,"rdSpend":41110000,"netIncome":-59001000,"cash":12388000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"NAUT-101 patent cliff ($0.0B at risk)","drug":"NAUT-101","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Nautilus Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Nautilus Biotechnology reported its financial results for the fourth quarter and full year 2023, with a net loss of $13.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Nautilus Biotechnology Announces Collaboration with Leading Pharmaceutical Company","summary":"Nautilus Biotechnology announced a collaboration with a leading pharmaceutical company to develop new protein-based therapeutics.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"pipeline","source":"simplywall.st","summary":"Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - simplywall.st","headline":"Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPTlllNjZYaE84UXlmVlBVMjV1Z2RyV0loSFFFSDJpU05hVVlEaTNUMUFINF9lUUhiN1RrMXpETmRrRHhHem1HaW1EZmI1M3k4bnp6RXVxR1dQMExMNDFPclltQXJ0NzdZMzhMQUdoRExJTU82VUhiaTVpMG5ZeWkyNmxmZW5pRy1kc2c?oc=5","date":"2026-03-06","type":"pipeline","source":"The Pharma Letter","summary":"Nautilus names Amber Faust VP of sales - The Pharma Letter","headline":"Nautilus names Amber Faust VP of sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxObnJobWZIM3ZHM2VHcUk5Z3NyY1dwLVJWQnBIVDBUR25GNm9IQjFncE1ydERjT05yWTNwbDV5ak9uSHdQWWJ1cVpyNHNDZGxhX21VTFFfaU9DNllJTHcwUXJHcmQ3Yjl1c3JqWHY0Q05SUmdteEE3MVBGM3VYcC1MejdWU2xQNGEzZ21xeHhLRjNjVVZ4U3duZHVUWDJkaG9IR3NCeVQyV1hXMW5PV2xwdFZQdm94aXl3dlQwb0h1Rkk5cHU4NURoUnFqTDNzX2FKbzBTdWx3?oc=5","date":"2026-03-02","type":"pipeline","source":"BioSpace","summary":"Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales - BioSpace","headline":"Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"pipeline","source":"simplywall.st","summary":"3 Penny Stocks With Market Caps Over $50M To Watch - simplywall.st","headline":"3 Penny Stocks With Market Caps Over $50M To Watch","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"deal","source":"simplywall.st","summary":"Nautilus Biotechnology Insiders May Regret Not Buying More, Market Cap Hits US$236m - simplywall.st","headline":"Nautilus Biotechnology Insiders May Regret Not Buying More, Market Cap Hits US$236m","sentiment":"neutral"},{"date":"2025-11-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-10-28","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-10-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-07-31","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYQWR3ZGhZdHdvT2ZvOGhwNVlKWnhfc1RKRmhzZTJ2akpBWExZajJLRFNEZWxfSzlrTUdlNWxVaUxpa3RaX3oyVmdmSndjSXN1RU1J?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"NAUT Stock Price, News & Analysis - Stock Titan","headline":"NAUT Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1OVU1WSG45bkdCUUFla25TS0tLbGVicFRaMzcySGJiWEZpVnZtVkNnZUJabURpNWxFNWdZVVd0dklzTVNuOFNJRlh3aGRBbWp3alE?oc=5","date":"2024-06-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Nautilus Biotechnology, Inc. (NAUT) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Nautilus Biotechnology, Inc. (NAUT) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9jMlltbDY3R2pvQjYxbVBNVG5ZQndhVlFrSjU3a1RUSk16WXd6a0thTzlzRlM2ZThvcUJWX29XdHdIRDhkVEM3djM2SmpRWUhGWHlzYzlISTlhZDhWdjBnN24zQ1pZUQ?oc=5","date":"2024-05-11","type":"pipeline","source":"MarketBeat","summary":"Nautilus Biotechnology (NAUT) Stock Forecast and Price Target 2026 - MarketBeat","headline":"Nautilus Biotechnology (NAUT) Stock Forecast and Price Target 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxNN0IyZTI2NHpRbjBMeG42eWZxejFSM3lHb0l3bFc1aU5TaUN5VFBEdlRsME5NVnZMS21VQ2FleFRBSTBic1RjM2VHZ0p1TTNkMWl3MnA0WUlDRWNvcmI5OHg3R3hZRHNFTEc0X3RZVUJZNElZU3IxX3JwYXNHdi1OTllLX3daNHpmVTFiV1o0dHdtNnl3STFTVFByVl9YOHhseUtuVUNOSXZhZTFoaGFoTFh3OE4tcElDYm9OaHBVNzFDMmdpNXN4SGRPX2ExQjJzMl9OSTRhOUp5Qmd5YWZxSFJvRldTUHhvQ1NrZXowWEJkZXJuZmlFNGpDd3d6S0JJejVKanFjQi1xWGFDTTZLdkdpcUU3VHZkT2Qzdmdn?oc=5","date":"2021-06-09","type":"pipeline","source":"GlobeNewswire","summary":"Nautilus Biotechnology Debuts as Publicly Traded Company, - GlobeNewswire","headline":"Nautilus Biotechnology Debuts as Publicly Traded Company,","sentiment":"neutral"}],"patents":[{"drugName":"NAUT-101","drugSlug":"naut-101","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Biogen","Pfizer","Amgen"],"therapeuticFocus":["Oncology","Autoimmune Diseases"],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":41110000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-59001000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":12388000,"cashHistory":[],"totalAssets":191112000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}